Literature DB >> 22102925

FDA approval for use of medications in pregnancy: an uphill battle.

Errol R Norwitz, James A Greenberg.   

Abstract

Year:  2011        PMID： 22102925      PMCID： PMC3218552     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN： 1941-2797


× No keyword cloud information.
  5 in total

1.  The Gordian knot of developing tocolytics.

Authors:  T Murphy Goodwin
Journal:  J Soc Gynecol Investig       Date:  2004-09

2.  U.S. Food and Drug Administration drug approval: slow advances in obstetric care in the United States.

Authors:  Deborah A Wing; Barbara Powers; Durlin Hickok
Journal:  Obstet Gynecol       Date:  2010-04       Impact factor: 7.661

3.  Estimating the cost of new drug development: is it really 802 million dollars?

Authors:  Christopher P Adams; Van V Brantner
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

4.  Spending on new drug development1.

Authors:  Christopher Paul Adams; Van Vu Brantner
Journal:  Health Econ       Date:  2010-02       Impact factor: 3.046

5.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245
  5 in total
  5 in total

1.  Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices.

Authors:  Paula M Frew; Diane S Saint-Victor; Margaret Brewinski Isaacs; Sonnie Kim; Geeta K Swamy; Jeanne S Sheffield; Kathryn M Edwards; Tonya Villafana; Ouda Kamagate; Kevin Ault
Journal:  Clin Infect Dis       Date:  2014-12-15       Impact factor: 9.079

2.  Ethics, regulation, and beyond: the landscape of research with pregnant women.

Authors:  Carla Saenz; Phaik Yeong Cheah; Rieke van der Graaf; Leslie Meltzer Henry; Anna C Mastroianni
Journal:  Reprod Health       Date:  2017-12-14       Impact factor: 3.223

3.  [An ethics call to include pregnant women in research: Reflections from the Global Forum on Bioethics in Research].

Authors:  Carla Saenz; Jackeline Alger; Juan Pablo Beca; José M Belizán; María Luisa Cafferata; Julio Arturo Canario Guzmán; Jesica E Candanedo P; Lissette Duque; Lester Figueroa; Ana Garcés; Lionel Gresh; Ida Cristina Gubert; Dirce Guilhem; Gabriela Guz; Gustavo Kaltwasser; A Roxana Lescano; Florencia Luna; Alexandrina A M Cardelli; Ignacio Mastroleo; Irene N Melamed; Agueda Muñoz Del Carpio Toia; Ricardo Palacios; Gloria I Palma; Sofía P Salas; Xochitl Sandoval; Sergio Surugi de Siqueira; Hans Vásquez; Bertha Ma Villela de Vega
Journal:  Rev Panam Salud Publica       Date:  2017-02-08

4.  Pediatric Off-Label Use of Covid-19 Vaccines: Ethical and Legal Considerations.

Authors:  Elizabeth Lanphier; Shannon Fyfe
Journal:  Hastings Cent Rep       Date:  2021-11-08       Impact factor: 4.298

5.  A review of clinical studies involving pregnant women registered in the Clinical Trials Registry of India.

Authors:  Sonali Rajiv Karekar; S G Pooja; Padmaja Anil Marathe
Journal:  Perspect Clin Res       Date:  2019-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.